|
|
| (16 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{Liver abscess}} | | {{Liver abscess}} |
| {{CMG}}; {{AE}} {{chetan}} | | {{CMG}}; {{AE}} {{SSK}} |
| | |
| Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
| |
|
| |
|
| ==Overview== | | ==Overview== |
| Treatment usually consists of placing a tube through the skin to drain the abscess. Less often, surgery is required. [[Antibiotic]]s are used for about 4 - 6 weeks. Sometimes, antibiotics alone can cure the infection.
| |
|
| |
| ===Antibiotic therapy===
| |
| Following are the guidelines for the treatment of hepatic abscess.<ref name="Lee-2008">{{Cite journal | last1 = Lee | first1 = SS. | last2 = Chen | first2 = YS. | last3 = Tsai | first3 = HC. | last4 = Wann | first4 = SR. | last5 = Lin | first5 = HH. | last6 = Huang | first6 = CK. | last7 = Liu | first7 = YC. | title = Predictors of septic metastatic infection and mortality among patients with Klebsiella pneumoniae liver abscess. | journal = Clin Infect Dis | volume = 47 | issue = 5 | pages = 642-50 | month = Sep | year = 2008 | doi = 10.1086/590932 | PMID = 18643760 }}</ref><ref name="Fang-2007">{{Cite journal | last1 = Fang | first1 = CT. | last2 = Lai | first2 = SY. | last3 = Yi | first3 = WC. | last4 = Hsueh | first4 = PR. | last5 = Liu | first5 = KL. | last6 = Chang | first6 = SC. | title = Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. | journal = Clin Infect Dis | volume = 45 | issue = 3 | pages = 284-93 | month = Aug | year = 2007 | doi = 10.1086/519262 | PMID = 17599305 }}</ref><ref name="Siu-2012">{{Cite journal | last1 = Siu | first1 = LK. | last2 = Yeh | first2 = KM. | last3 = Lin | first3 = JC. | last4 = Fung | first4 = CP. | last5 = Chang | first5 = FY. | title = Klebsiella pneumoniae liver abscess: a new invasive syndrome. | journal = Lancet Infect Dis | volume = 12 | issue = 11 | pages = 881-7 | month = Nov | year = 2012 | doi = 10.1016/S1473-3099(12)70205-0 | PMID = 23099082 }}</ref>
| |
| **Pending determination of bacterial versus amoebic liver abscess
| |
| :*Preferred regimen (1): [[Metronidazole]] 30-40 mg/kg/day in 3 divided doses IV q8h or 500 mg po q6-8h {{and}} [[Ceftriaxone]] 1-2 gm IV q24h {{or}} [[Piperacillin-Tazobactam]] 3.375 gm IV q4-6h
| |
| :*Preferred regimen (2): [[Metronidazole]] 30-40 mg/kg/day in 3 divided doses IV q8h or 500 mg po q6-8h {{and}} [[Ciprofloxacin]] 400 mg IV q12h 750 mg po {{or}} Levofloxacin 750 mg po/IV q24h
| |
| :*Alternate Regimen: [[Metronidazole]] 30-40 mg/kg/day in 3 divided doses IV q8h or 500 mg po q6-8h {{and}} [[Ertapenem]] 1 gm q24h
| |
| *If bacterial etiology is suspected then follow these guidelines:
| |
| #CT guided percutaneous or drainage through surgery should be performed.
| |
| #If anaerobic bacterial infection is suspected, stop metronidazole and start with [[piperacillin tazobactam]] or [[ertapenem]]. (
| |
| #[[Bacteroides]] should be treated with empiric metronidazole.
| |
| #If [[hemochromatosis]] is associated with liver abscess then suspect [[Yersinia enterocolitica]].
| |
| #If pyogenic liver abcess is suspected then the source of infection is either in biliary tract disease or other identifiable GI source.
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |
| {{WH}}
| |
| {{WS}}
| |
| [[Category:Needs content]]
| |
| [[Category:Gastroenterology]]
| |
| [[Category:Infectious disease]]
| |
| [[Category:Mature chapter]]
| |
| [[Category:Disease]]
| |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Serge Korjian M.D.
Overview